The 2023 ASCO Gastrointestinal Cancers Symposium will host world-renowned experts in gastrointestinal cancers and this international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of breast cancer. Watch exclusive interviews from ASCO GI 2023 to keep up to date with the latest in gastrointestinal cancers!
View all videos

ASCO GI 2023

ASCO Gastrointestinal Cancers Symposium 2023
19–21 January 2023 | San Francisco, CA
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🎥 @changhoon_yoo of @AsanMedicalCtr talks on the impact of immunotherapy and checkpoint inhibition in treating HCC

Watch: 👉http://ow.ly/ispZ50MINVh👈

@ASCO #GI23 #GastrointestinalCancer #HPBCSM

Reply on Twitter 1621916812106407937Retweet on Twitter 1621916812106407937Like on Twitter 1621916812106407937Twitter 1621916812106407937
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🌎 Today marks #WorldCancerDay2023, and visit our website at http://VJOncology.com as we continue to update you on the latest in #oncology with exclusive interviews, insightful sessions, and more!

#BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm @uicc

Reply on Twitter 1621856377676120065Retweet on Twitter 1621856377676120065Like on Twitter 16218563776761200651Twitter 1621856377676120065
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

This week's podcast is an overview of updates in biliary tract cancer at ASCO GI with Ghassan Abou-Alfa (@GABOUALFA).

Listen here: 🎧 http://ow.ly/TP8a50MIWeg 🎧

#HPBCSM #GastrointestinalCancer @ASCO #GI23

Reply on Twitter 1621841373975429120Retweet on Twitter 1621841373975429120Like on Twitter 1621841373975429120Twitter 1621841373975429120
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🎥 @adasarimd of @MDAndersonNews discusses updates from the CIRCULATE-US trial

Watch: 👉http://ow.ly/PYMe50MINTU👈

@ASCO #GI23 #GastrointestinalCancer #CRCSM #ColorectalCancer

Reply on Twitter 1621795899356725248Retweet on Twitter 1621795899356725248Like on Twitter 16217958993567252481Twitter 1621795899356725248
VJOncologyVJ Oncology@VJOncology·
February 3, 2023

🎥 @NataliyaUboha of @UWCarbone talks on targeting CLDN18.2 with zolbetuximab in gastric and GEJ cancer

Watch: 👉http://ow.ly/JnFx50MINSY👈

@ASCO #GI23 #GastrointestinalCancer #GastricCancer #STCSM #ESOCSM

Reply on Twitter 1621554647004585986Retweet on Twitter 1621554647004585986Like on Twitter 1621554647004585986Twitter 1621554647004585986
Load More

ASCO GI 2023

ASCO Gastrointestinal Cancers Symposium 2023
19–21 January 2023 | San Francisco, CA
The 2023 ASCO Gastrointestinal Cancers Symposium will host world-renowned experts in gastrointestinal cancers and this international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of breast cancer. Watch exclusive interviews from ASCO GI 2023 to keep up to date with the latest in gastrointestinal cancers!
View all videos
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🎥 @changhoon_yoo of @AsanMedicalCtr talks on the impact of immunotherapy and checkpoint inhibition in treating HCC

Watch: 👉http://ow.ly/ispZ50MINVh👈

@ASCO #GI23 #GastrointestinalCancer #HPBCSM

Reply on Twitter 1621916812106407937Retweet on Twitter 1621916812106407937Like on Twitter 1621916812106407937Twitter 1621916812106407937
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🌎 Today marks #WorldCancerDay2023, and visit our website at http://VJOncology.com as we continue to update you on the latest in #oncology with exclusive interviews, insightful sessions, and more!

#BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm @uicc

Reply on Twitter 1621856377676120065Retweet on Twitter 1621856377676120065Like on Twitter 16218563776761200651Twitter 1621856377676120065
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

This week's podcast is an overview of updates in biliary tract cancer at ASCO GI with Ghassan Abou-Alfa (@GABOUALFA).

Listen here: 🎧 http://ow.ly/TP8a50MIWeg 🎧

#HPBCSM #GastrointestinalCancer @ASCO #GI23

Reply on Twitter 1621841373975429120Retweet on Twitter 1621841373975429120Like on Twitter 1621841373975429120Twitter 1621841373975429120
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🎥 @adasarimd of @MDAndersonNews discusses updates from the CIRCULATE-US trial

Watch: 👉http://ow.ly/PYMe50MINTU👈

@ASCO #GI23 #GastrointestinalCancer #CRCSM #ColorectalCancer

Reply on Twitter 1621795899356725248Retweet on Twitter 1621795899356725248Like on Twitter 16217958993567252481Twitter 1621795899356725248
VJOncologyVJ Oncology@VJOncology·
February 3, 2023

🎥 @NataliyaUboha of @UWCarbone talks on targeting CLDN18.2 with zolbetuximab in gastric and GEJ cancer

Watch: 👉http://ow.ly/JnFx50MINSY👈

@ASCO #GI23 #GastrointestinalCancer #GastricCancer #STCSM #ESOCSM

Reply on Twitter 1621554647004585986Retweet on Twitter 1621554647004585986Like on Twitter 1621554647004585986Twitter 1621554647004585986
Load More

Catch up on highlights from ASCO GI 2023!

View all
1:07
KEYMAKER-U06 substudy 06A: favezelimab or MK-4380 in esophageal cancer
Ken Kato • 19 Jan 2023
1:19
29-month follow-up from CheckMate 648: nivolumab combination therapy in ESCC
Ken Kato • 19 Jan 2023
0:27
What to look out for at ASCO GI 2023
Changhoon Yoo • 19 Jan 2023
1:10
Predicting survival outcomes in colorectal cancer with the STING pathway
Heinz-Josef Lenz • 19 Jan 2023

Colorectal cancer

View all
1:10
Predicting survival outcomes in colorectal cancer with the STING pathway
Heinz-Josef Lenz • 19 Jan 2023
0:51
Addressing resistance to ICIs in colorectal cancer
Heinz-Josef Lenz • 19 Jan 2023
0:51
Key clinical trial updates from ASCO GI 2023
Rachna Shroff • 19 Jan 2023
2:42
PARADIGM: panitumumab versus bevacizumab in RAS-wt mCRC
Kohei Shitara • 19 Jan 2023

Gastroesophageal Cancer

View all
0:58
LB1908: a novel CAR-T cell therapy targeting claudin 18.2 in GI malignancies
David Bing Zhen • 19 Jan 2023
3:26
INFINTY: tremelimumab and durvalumab in MSI-high GC/GEJC
Filippo Pietrantonio • 19 Jan 2023
1:22
3-year follow-up of CheckMate 649: nivolumab + chemotherapy in GC/GEJC/EAC
Kohei Shitara • 19 Jan 2023
2:49
SPOTLIGHT: zolbetuximab and m-FOLFOX6 in CLDN18.2+, HER2- GEJ cancer
Kohei Shitara • 19 Jan 2023

Pancreatic cancer

View all
0:58
LB1908: a novel CAR-T cell therapy targeting claudin 18.2 in GI malignancies
David Bing Zhen • 19 Jan 2023
0:51
Key clinical trial updates from ASCO GI 2023
Rachna Shroff • 19 Jan 2023
0:43
daNIS-2: NIS793 with nab-paclitaxel and gemcitabine in mPDAC
Zev Wainberg • 20 Jan 2023
0:54
NAPOLI-3: first-line NALIRIFOX in metastatic pancreatic ductal adenocarcinoma
Zev Wainberg • 20 Jan 2023
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals